Skip to Main Content

Paper Details

TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors.
Cancer Med
4
2023
Author NameAffiliation
Kyoung-Mee KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Jeeyun LeeSamsung Medical Center, Sungkyunkwan University School of Medicine
Jeeyun LeeInnovative Institute for Precision Medicine, Samsung Medical Center
  • 1 - 3

Datasets

Release 1.2